Traws Pharma, Inc.

TRAW Nasdaq SEC CIK 1130598
Follow Traws Pharma Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$3.5M +10.5% vs same quarter last year
EPS, diluted −$0.18 +47.1% vs same quarter last year
Operating cash flow −$2.5M +38.2% vs same quarter last year
Operating income −$3.6M +11.2% vs same quarter last year
Revenue by quarter
$56K
$57K
$2.7M
$0
$0
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$200M−$100M$0$100MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$2.8M$9.2M
FY24$226K−$166.5M
FY23$226K−$18.9M
FY22$226K−$19M
FY21$226K−$16.2M
FY20$231K−$25.2M
FY19$2.2M−$21.5M
FY18$1.2M−$20.6M
FY17$787K−$24.1M
FY16$5.5M−$19.7M
FY15$11.5M−$24M
FY14$800K−$63.7M
FY13$4.8M−$62.5M
FY12$46.2M−$29.9M
FY11$1.5M−$26.3M
MarginsShare of revenue
  • Operating margin
  • Net margin
−80000%−60000%−40000%−20000%0%20000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearOperating marginNet margin
FY25−640.7%328.7%
FY24−62997.3%−73682.7%
FY23−8981.4%−8384.1%
FY22−8684.5%−8391.2%
FY21−7299.1%−7151.8%
FY20−10819.5%−10890.5%
FY19−994%−985%
FY18−1895.9%−1675.3%
FY17−3270.3%−3061.2%
FY16−427.4%−354.6%
FY15−209.3%−209.3%
FY14−7968%−7960.2%
FY13−1309.1%−1315.9%
FY12−48.2%−64.8%
FY11−1854.3%−1768.3%
Free cash flowOperating cash flow minus capital expenditure
−$80M−$60M−$40M−$20M$0$20MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$20.8M
FY24−$33.4M
FY23−$17.9M
FY22-
FY21-
FY20−$23.1M
FY19−$20.9M
FY18-
FY17-
FY16-
FY15-
FY14−$57.9M
FY13−$62M
FY12$1.4M
FY11−$14.4M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Traws Pharma
  • Healthcare median
−80000%−60000%−40000%−20000%0%20000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearTraws PharmaHealthcare median
FY25328.7%−30.6%
FY24−73682.7%−47%
FY23−8384.1%−58%
FY22−8391.2%−80.4%
FY21−7151.8%−71.9%
FY20−10890.5%−62.2%
FY19−985%−46.3%
FY18−1675.3%−49.6%
FY17−3061.2%−45.9%
FY16−354.6%−36%
FY15−209.3%−38.4%
FY14−7960.2%−35.5%
FY13−1315.9%−37.1%
FY12−64.8%−29.1%
FY11−1768.3%−27.9%